evaluate the pharmaceuticals and biotechnology company novo nordisk on glp-1's testing its blockbuster GLP-1 drugs in Alzheimer's Novo Nordisk was the first

Novel therapeutic strategies for traumatic brain injury: acute antioxidant reinforcement

FDA-approved GLP-1 receptor agonists represent a distinct class of prescription medications with well-established efficacy and safety profiles

A) all generic cos were very low on their GLP1 forecast before the launch - a few 10s of crores at best in the 1st year eg A top co in India had a 10cr first yr sales forecast and is set to do a multiplier of that On top of that fewer than expected cos have launched B) online sales which is the biggest area of growth on GLP1s (pharmacies / Telehealth) doesnt get captured and so is direct sales

Its a synthetic peptide derived from a protective protein found naturally in your stomach

Clinical eligibility for GLP-1 drugs was determined using BMI and the following comorbidities as specified in NHIS: coronary heart disease, prior stroke, prior heart attack, angina, high blood pressure, and high cholesterol

What are the potential side effects of glutathione injections or IV on the skin